Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker FDMT
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 12, 2026 | FDMT 4D Molecular Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Sep 28, 2026 | FDMT 4D Molecular Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Aug 13, 2026 | FDMT 4D Molecular Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jul 20, 2026 | FDMT 4D Molecular Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jun 29, 2026 | FDMT 4D Molecular Therapeutics, Inc. | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Jun 29, 2026 | FDMT 4D Molecular Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jun 22, 2026 | FDMT 4D Molecular Therapeutics, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 7, 2026 | FDMT 4D Molecular Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 30, 2026 | FDMT 4D Molecular Therapeutics, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Mar 18, 2026 | FDMT 4D Molecular Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jan 26, 2026 | FDMT 4D Molecular Therapeutics, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Jan 7, 2026 | FDMT 4D Molecular Therapeutics, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Jan 7, 2026 | FDMT 4D Molecular Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Dec 10, 2025 | FDMT 4D Molecular Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 17, 2025 | FDMT 4D Molecular Therapeutics, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Nov 10, 2025 | FDMT 4D Molecular Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 7, 2025 | FDMT 4D Molecular Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 6, 2025 | FDMT 4D Molecular Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 6, 2025 | FDMT 4D Molecular Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 31, 2025 | FDMT 4D Molecular Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Oct 2, 2025 | FDMT 4D Molecular Therapeutics, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Oct 2, 2025 | FDMT 4D Molecular Therapeutics, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Aug 11, 2025 | FDMT 4D Molecular Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jul 2, 2025 | FDMT 4D Molecular Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jul 2, 2025 | FDMT 4D Molecular Therapeutics, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Jun 20, 2025 | FDMT 4D Molecular Therapeutics, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 8, 2025 | FDMT 4D Molecular Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 28, 2025 | FDMT 4D Molecular Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 10, 2025 | FDMT 4D Molecular Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jan 10, 2025 | FDMT 4D Molecular Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jan 10, 2025 | FDMT 4D Molecular Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Dec 11, 2024 | FDMT 4D Molecular Therapeutics, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Nov 13, 2024 | FDMT 4D Molecular Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
33 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:30 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances